-
2026 - 2027 Validation Report: Savings & Metrics With TempraMed
VALIDATION INSTITUTE Claim Assertion for Validation By providing a temperature shield to medications in-use which degrade when exposed to temperatures exceeding “room temperatures” or below freezing, for patients that spend time outdoors with their medication, the VIVI CAP device can provide significant savings. Some of the savings is almost... -
VIVI Cap Stabilizes Insulin in Extreme Temperature Conditions
Andreas Pfützner 1, Wolfgang Reeh2, Ron Nagar3, Dirk Rose4, 1Pfützner Science & Health Institute, Diabetes Center and Practice, Mainz, Germany; 2Diabetes Care Centre, Oppenheim, Germany 3TempraMed Inc., Tel Aviv, Israel; 4Flymed Aviation Centre, Frankfurt, Germany Introduction For long-term storage, Insulin is to be kept at 4-8°... -
Technology-derived storage solutions for stabilizing insulin in extreme weather conditions I: the ViViCap-1 device
PMID: 28394190 DOI: 10.1080/17425247.2017.1316261 Abstract Background: Injectable life-saving drugs should not be exposed to temperatures <4°C/39°F or >30°C/86°F. Frequently, weather conditions exceed these temperature thresholds in many countries. Insulin is to be kept at 4-8°C/~ 39-47°F until use and once opened, is supposed to be stable...





